Terumo (OTCMKTS:TRUMY) Shares Down 5.3% – Here’s Why
by Teresa Graham · The Cerbat GemShares of Terumo Corp. (OTCMKTS:TRUMY – Get Free Report) were down 5.3% during mid-day trading on Friday . The company traded as low as $13.90 and last traded at $13.90. Approximately 5,372 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 251,850 shares. The stock had previously closed at $14.68.
Analyst Ratings Changes
Separately, Nomura upgraded Terumo from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, Terumo currently has a consensus rating of “Buy”.
Check Out Our Latest Stock Report on Terumo
Terumo Trading Down 3.7%
The company has a fifty day simple moving average of $14.98 and a two-hundred day simple moving average of $14.04. The company has a market capitalization of $20.85 billion, a P/E ratio of 19.91 and a beta of 0.68. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.19 and a quick ratio of 1.37.
Terumo (OTCMKTS:TRUMY – Get Free Report) last issued its quarterly earnings results on Friday, August 7th. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.17 by $0.13. Terumo had a return on equity of 10.44% and a net margin of 13.83%.The company had revenue of $1.97 billion for the quarter, compared to the consensus estimate of $1.84 billion. On average, analysts forecast that Terumo Corp. will post 0.7 earnings per share for the current fiscal year.
About Terumo
Terumo Corporation is a Japan-based medical technology company that develops, manufactures and sells products used in hospitals, clinics and other health care settings. Founded in 1921, the company has grown from producing clinical thermometers into a global provider of medical devices and related solutions.
Terumo’s businesses include cardiovascular and vascular intervention products, such as catheters, guidewires and other devices used in the treatment of heart and vascular conditions.